Kazia Therapeutics (KZIA) Net Shares Issued and Repurchased (2009 - 2025)

Kazia Therapeutics' Net Shares Issued and Repurchased history runs 17 years deep, the most recent figure standing at $122.5 million for Q4 2025.

• Quarterly Net Shares Issued and Repurchased rose 59.5% year-over-year to $122.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $122.5 million (up 59.5% YoY) and the FY2025 annual result came in at $78.8 million, up 17.65% from the prior year.
• Net Shares Issued and Repurchased was $122.5 million for Q4 2025 at Kazia Therapeutics, up from $78.8 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $122.5 million in Q4 2025 and bottomed at $58.5 million in Q4 2021.
• A 5-year average of $71.5 million and a median of $64.7 million in 2023 frame the typical range for Net Shares Issued and Repurchased.
• Annual changes were most pronounced in 2021 — Net Shares Issued and Repurchased soared 93.38% — and 2022, when it retreated 2.13%.
• Kazia Therapeutics' Net Shares Issued and Repurchased stood at $58.5 million in 2021, then rose by 1.46% to $59.4 million in 2022, then advanced by 8.33% to $64.3 million in 2023, then climbed by 19.45% to $76.8 million in 2024, then jumped by 59.5% to $122.5 million in 2025.
• Business Quant data shows KZIA's Net Shares Issued and Repurchased at $122.5 million in Q4 2025, $78.8 million in Q2 2025, and $76.8 million in Q4 2024.